2008-03-26 INCREASED MORTALITY, CV, THROMBOEMBOLIC EVENTS, AND TUMOR PROGRESSION WITH THE ERYTHROCYTE STIMULATING AGENTS (ESAs) ARANESP, EPREX, RECORMON
2008-02-27 Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial